عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
 
 
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

NCR graphs - Incidence rates by site

- 2024: Incidence rates for top 15 primary sites, males
- 2024: Incidence rates for top 15 primary sites, females

- 2023: Incidence rates for top 15 primary sites, males
- 2023: Incidence rates for top 15 primary sites, females

- 2022: Incidence rates for top 15 primary sites, males
- 2022: Incidence rates for top 15 primary sites, females

- 2021: Incidence rates for top 15 primary sites, males
- 2021: Incidence rates for top 15 primary sites, females

- 2020: Incidence rates for top 15 primary sites, males
- 2020: Incidence rates for top 15 primary sites, females

- 2019: Incidence rates for top 15 primary sites, males
- 2019: Incidence rates for top 15 primary sites, females

- 2018: Incidence rates for top 15 primary sites, males
- 2018: Incidence rates for top 15 primary sites, females

- 2017: Incidence rates for top 15 primary sites, males
- 2017: Incidence rates for top 15 primary sites, females

- 2016: Incidence rates for top 15 primary sites, males
- 2016: Incidence rates for top 15 primary sites, females

- 2015: Incidence rates for top 15 primary sites, males
- 2015: Incidence rates for top 15 primary sites, females

- 2014: Incidence rates for top 15 primary sites, males
- 2014: Incidence rates for top 15 primary sites, females

- 2013: Incidence rates for top 15 primary sites, males
- 2013: Incidence rates for top 15 primary sites, females

- 2012: Incidence rates for top 15 primary sites, males
- 2012: Incidence rates for top 15 primary sites, females

- 2011: Incidence rates for top 15 primary sites, males
- 2011: Incidence rates for top 15 primary sites, females

- 2010: Incidence rates for top 15 primary sites, males
- 2010: Incidence rates for top 15 primary sites, females

- 2009: Incidence rates for top 15 primary sites, males
- 2009: Incidence rates for top 15 primary sites, females

- 2008: Incidence rates for top 15 primary sites, males
- 2008: Incidence rates for top 15 primary sites, females

- 2007: Incidence rates for top 15 primary sites, males
- 2007: Incidence rates for top 15 primary sites, females

- 2006: Incidence rates for top 15 primary sites, males
- 2006: Incidence rates for top 15 primary sites, females

- 2005: Incidence rates for top 15 primary sites, males
- 2005: Incidence rates for top 15 primary sites, females
 
    1
    ...
    189
    190
    191
    192
    193
    194
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
L01FA01 ZYTUX BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 27,724,196 L.L
J01XX08 ZYVOX B Linezolide - 600mg 600mg Tablet 35,584,461 L.L
J01XX08 ZYVOX IV B Linezolide - 600mg/300ml 600mg/300ml Injectable solution 4,414,523 L.L
N01BB02 α 1% LIDOCAINE HCL USP G Lidocaine HCl - 1% 1% Injectable solution 76,791 L.L
N01BB02 α 2% LIDOCAINE HCL USP G Lidocaine HCl - 2% 2% Injectable solution 255,970 L.L
H02AB02 α DEXAMETHASONE SODIUM PHOSPHATE USP G Dexamethasone (sodium phosphate) - 8mg/2ml 8mg/2ml Injectable solution 44,795 L.L
C03CA01 α FUROSEMIDE INJECTION G Furosemide - 20mg/ml 20mg/ml Injectable solution 25,597 L.L
A03BB01 α HYOSCINE BUTYLBROMIDE G Hyoscine butylbromide - 20mg/ml 20mg/ml Injectable solution 70,392 L.L
M01AE01 α IBUPROFEN G Ibuprofen - 400mg/100ml 400mg/100ml Injectable solution 383,955 L.L
A03FA01 α METOCLOPRAMIDE INJECTION USP G Metoclopramide HCl - 10mg/2ml 10mg/2ml Injectable solution 84,470 L.L
P01AB01 α METRONIDAZOL G Metronidazole - 500mg/100ml 500mg/100ml Injectable solution 162,541 L.L
C01CA03 α NORADRENALINE G Norepinephrine tartrate - 8mg/4ml 8mg/4ml Injectable solution 330,201 L.L
A04AA01 α ONDANSETRON USP G Ondansetron - 8mg/4ml 8mg/4ml Injectable solution 447,948 L.L
N02BE01 α PARACETAMOL G Paracetamol - 1g/100ml 1g/100ml Injectable solution 191,978 L.L
N03AB02 α PHENYTOIN SODIUM 5% USP G Phenytoin (sodium) - 250mg/5ml 5ml Injectable solution 276,448 L.L
V03AB35 α SUGAMMADEX G Sugammadex - 200mg/2ml 100mg/ml Injectable solution 5,214,109 L.L
    1
    ...
    189
    190
    191
    192
    193
    194
Sitemap
© Copyrights reserved to Ministry of Public Health 2026